A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Jan Schnorr, CEO, C2Sense
Opportunity to collaborate with industry experts, customers, and Schneider Electric leaders.
The 2026 MIT Enterprise AI Forum will spotlight cutting‑edge Enterprise AI strategies, practical frameworks, and breakthrough applications across mission‑critical domains such as real-time digital twins, automated defect detection, and intelligent product lifecycle management.